曾昭武1,2 肖人钟2 王小丽1△ 刘星言1.聚乙二醇- 聚乳酸嵌段共聚物纳米粒的研究进展[J].,2012,12(1):179-182 |
聚乙二醇- 聚乳酸嵌段共聚物纳米粒的研究进展 |
Study Progress of Polyethylene Glycol-Polylactic Acid Block CopolymerNanoparticles |
|
DOI: |
中文关键词: 聚乙二醇- 聚乳酸 纳米粒 药物传递系统 |
英文关键词: PEG-PLA Nanoparticle Drug delivery system |
基金项目:国家自然科学青年基金项目(81001647);浙江省科技厅资助项目(2009C33005);中国博士后科学基金面上项目(20100471757) |
|
摘要点击次数: 909 |
全文下载次数: 4110 |
中文摘要: |
聚乙二醇- 聚乳酸嵌段共聚物(PEG-PLA)及其端基衍生物纳米粒可以增强载药量、降低突释效应、提高药物在血液中的循
环时间、提高生物利用度,并且其粒径更小,能以被动靶向的方式聚集于炎症或靶向部位。本文综述了PEG-PLA 嵌段共聚物纳米
粒的最新进展,包括PEG-PLA 的合成、纳米粒的制备、释药特性及在药物制剂中的应用。 |
英文摘要: |
Polyethylene glycol-polylactic acid (PEG-PLA) block copolymer and its end-group derivative nanoparticles may enhance
the drug-loading rate, reduce the burst effect, extend drug circulation time in blood and improve bioavailability. Moreover, because
of their smaller particle size and modified surface, these nanoparticles may accumulate in inflammation or target locations by passive targeting
to enhance drug efficacy and reduce toxicity. Recent progress in PEG-PLA block copolymer nanoparticles, including the synthesis
of PEG-PLA and the preparation of PEG-PLA nanoparticles, the drug release characteristics and their application in pharmaceutical
preparations were introduced in this review. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |